当前位置:首页 - 行情中心 - 赛伦生物(688163) - 财务分析

赛伦生物

(688163)

  

流通市值:6.50亿  总市值:15.84亿
流通股本:4437.20万   总股本:1.08亿

赛伦生物(688163)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.01亿元,每股收益0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益108731.54万元,未分配利润5518.96万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产112296.56万元,负债3565.02万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入26,301,356.47190,144,196.65166,133,808.1193,759,588.31
营业总成本28,345,641.29150,176,048.43111,754,125.9266,786,383.11
营业利润1,935,383.3945,983,980.3158,884,729.330,410,142.68
利润总额1,916,280.1445,415,269.258,734,658.730,362,341.6
净利润1,474,787.0438,774,331.6350,797,820.5326,909,324.11
其他综合收益----
综合收益总额1,474,787.0438,774,331.6350,797,820.5326,909,324.11
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计940,355,041.14948,930,376.53956,456,829.05936,094,130.87
非流动资产合计182,610,585.25179,542,169.1172,682,077.08170,377,261.05
资产总计1,122,965,626.391,128,472,545.631,129,138,906.131,106,471,391.92
流动负债合计17,848,273.1324,985,772.6820,202,637.6920,897,132.61
非流动负债合计17,801,960.7517,646,167.4817,672,174.0718,198,661.36
负债合计35,650,233.8842,631,940.1637,874,811.7639,095,793.97
归属于母公司股东权益合计1,087,315,392.511,085,840,605.471,091,264,094.371,067,375,597.95
股东权益合计1,087,315,392.511,085,840,605.471,091,264,094.371,067,375,597.95
负债和股东权益合计1,122,965,626.391,128,472,545.631,129,138,906.131,106,471,391.92
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计13,330,139.18184,789,224.5143,456,307.3153,817,981.19
经营活动现金流出小计35,126,590.56151,969,300.58124,716,492.6672,705,933.26
经营活动产生的现金流量净额-21,796,451.3832,819,923.9218,739,814.65-18,887,952.07
投资活动现金流入小计724,226,729.972,707,733,663.251,983,947,745.451,253,654,436.9
投资活动现金流出小计729,272,8583,023,674,773.372,315,515,618.541,565,714,658.85
投资活动产生的现金流量净额-5,046,128.03-315,941,110.12-331,567,873.09-312,060,221.95
筹资活动现金流入小计----
筹资活动现金流出小计-81,843,992.581,157,50081,157,500
筹资活动产生的现金流量净额--81,843,992.5-81,157,500-81,157,500
汇率变动对现金及现金等价物的影响14,507.36156,656.85253,488.94257,909.6
现金及现金等价物净增加额-26,828,072.05-364,808,521.85-393,732,069.5-411,847,764.42
期末现金及现金等价物余额124,093,875.96150,921,948.01121,998,400.36103,882,705.44
TOP↑